Evidence map›Paper›PMID 30842760›Full record

ArticleFrontiers in microbiology2019

Lisa Quigley, Mairéad Coakley, Debebe Alemayehu, Mary C Rea, Patrick G Casey, Órla O'Sullivan, Eileen Murphy, Barry Kiely, Paul D Cotter, Colin Hill and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Clostridioides difficile and the Microbiota Early in Life.Journal of the Pediatric Infectious Diseases Society · 2021
    Review
  6. Article
  7. Review
  8. Ultrapotent Inhibitor ofJournal of medicinal chemistry · 2020
    Article
  9. Article
  10. Review
  11. Bacteriocins From LAB and Other Alternative Approaches for the Control ofFrontiers in bioengineering and biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lisa QuigleyTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Mairéad CoakleyTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Debebe AlemayehuTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Mary C ReaTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Patrick G CaseyAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Órla O'SullivanTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Eileen MurphyAlimentary Health Ltd., Cork, Ireland.
Barry KielyAlimentary Health Ltd., Cork, Ireland.
Paul D CotterTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Colin HillAPC Microbiome Ireland, University College Cork, Cork, Ireland.
R Paul RossTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

C. difficile infection (CDI)Clostridium difficileLactobacillus gasserilive therapeutic agentmurine model

Identifiers

PMID30842760
PMCPMC6391587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.